| ACS | Acute Coronary Syndrome |
| AMI | Acute Myocardial Infarction |
| AUC | Area under the curve |
| AUROC | Area under the receiver operating characteristic |
| CAPRICORN | CArvedilol Post-infaRct survIval COntRolled evaluatioN |
| EPHESUS | Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction |
| GRACE | Global Registry of Acute Coronary Events |
| GUSTO | Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries |
| ICU | Intensive Care Unit |
| LASSO | Least Absolute Shrinkage and Selection Operator |
| MINAP | Myocardial Ischemia National Audit Project |
| NSTEMI | Non-ST-Elevation Myocardial Infarction |
| NT-proBNP | N-terminal prohormone of brain natriuretic peptide |
| OASIS | Oxford Acute Severity of Illness Score |
| OPTIMAAL | Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan |
| PCI | Percutaneous Coronary Intervention |
| PPCI | Primary Percutaneous Coronary Intervention |
| PURSUIT | Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin |
| ROC | Receiver operating characteristic |
| STEMI | ST-Elevation Myocardial Infarction |
| TIMI | Thrombolysis in Myocardial Infarction |
| VALIANT | VALsartan In Acute Myocardial Infarction |
| VIF | Variance Inflation Factor |